AROSIO, ALESSANDRO
AROSIO, ALESSANDRO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model
2011 Stefanoni, G; Sala, G; Arosio, A; Melchionda, L; Saracchi, E; Fermi, S; Brighina, L; Ferrarese, C
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease
2011 Sala, G; Stefanoni, G; Arosio, A; Melchionda, L; Saracchi, E; Fermi, S; Brighina, L; Ferrarese, C
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model
2011 Stefanoni, G; Sala, G; Arosio, A; Melchionda, L; Saracchi, E; Fermi, S; Brighina, L; Ferrarese, C
Myocyte enhancer factor-2D expression in ALS lymphomonocytes
2012 Tremolizzo, L; Sala, G; Conti, E; Arosio, A; RODRIGUEZ MENENDEZ, V; Ferrarese, C
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells
2013 Stefanoni, G; Sala, G; Arosio, A; Riva, C; Marinig, D; Brighina, L; Ferrarese, C
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease
2013 Sala, G; Stefanoni, G; Arosio, A; Riva, C; Marinig, D; Saracchi, E; Fermi, S; Brighina, L; Ferrarese, C
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease
2013 Stefanoni, G; Sala, G; Arosio, A; Riva, C; Marinig, D; Saracchi, E; Brighina, L; Ferrarese, C
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition
2013 Sala, G; Arosio, A; Stefanoni, G; Melchionda, L; Riva, C; Marinig, D; Brighina, L; Ferrarese, C
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity
2014 Tremolizzo, L; Pellegrini, A; Arosio, A; Conti, E; Susani, E; Lunetta, C; Appollonio, I; Ferrarese, C
Micrornas in als: from molecular mechanisms to clinical relevance
2014 Tremolizzo, L; Loffreda, A; Arosio, A; Lunetta, C; Ferrarese, C; Barabino, S
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease
2014 Sala, G; Stefanoni, G; Arosio, A; Riva, C; Melchionda, L; Saracchi, E; Fermi, S; Brighina, L; Ferrarese, C
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis
2015 Arosio, A; Sala, G; Gerardi, F; RODRIGUEZ MENENDEZ, V; Lunetta, C; Tremolizzo, L; Ferrarese, C
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis
2015 Arosio, A; Sala, G; Gerardi, F; RODRIGUEZ MENENDEZ, V; Lunetta, C; Tremolizzo, L; Ferrarese, C
Study of transcriptional alterations in Amyotrophic Lateral Sclerosis
2015 Arosio, A
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells
2015 Tremolizzo, L; Arosio, A; Sala, G; RODRIGUEZ MENENDEZ, V; Gerardi, F; Lunetta, C; Ferrarese, C
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple
2015 Tremolizzo, L; Loffreda, A; Arosio, A; Gerardi, F; Lunetta, C; Ferrarese, C; Barabino, S
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis
2015 Arosio, A; Sala, G; Gerardi, F; RODRIGUEZ MENENDEZ, V; Lunetta, C; Tremolizzo, L; Ferrarese, C
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease
2015 Sala, G; Marinig, D; Riva, C; Colangelo, A; Arosio, A; Stefanoni, G; Brighina, L; Alberghina, L; Ferrarese, C
the MonzALS collaborative network
2015 Tremolizzo, L; Arosio, A; Conti, E; Grana, D; Sala, G; Cereda, D; Ferrarese, C
In vitro study of autophagy dysfunctions associated with Parkinson’s disease
2015 Marinig, D; Riva, C; Arosio, A; Colangelo, A; Brighina, L; Ferrarese, C; Sala, G